Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04194801
What this trial is testing

A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
CStone Pharmaceuticals 26
Testing effectiveness (Phase 2)Ended earlyNCT05199285
What this trial is testing

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+8 more
Academic and Community Cancer Research United 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05822752
What this trial is testing

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AbbVie 130
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Ended earlyNCT00971126
What this trial is testing

Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Health Research Institutes, Taiwan 3
Early research (Phase 1)Ended earlyNCT03998033
What this trial is testing

Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more
Eureka Therapeutics Inc. 2
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)UnknownNCT03499626
What this trial is testing

Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced/ Metastatic Hepatocellular Carcinoma
National University Hospital, Singapore 22
Early research (Phase 1)Ended earlyNCT00767468
What this trial is testing

Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 6
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01766219
What this trial is testing

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+6 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Looking for participantsNCT05705492
What this trial is testing

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Biliary Tract CarcinomaAdvanced Esophageal Carcinoma+7 more
OHSU Knight Cancer Institute 66
Early research (Phase 1)Active Not RecruitingNCT03993873
What this trial is testing

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorsMET Gene Alterations
Turning Point Therapeutics, Inc. 95
Early research (Phase 1)Temporarily pausedNCT06968195
What this trial is testing

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaRecurrent Hepatocellular Carcinoma+3 more
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT04401800
What this trial is testing

Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
BeiGene 64
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT04864054
What this trial is testing

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Neoplasm+1 more
Eureka Therapeutics Inc. 60
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Not applicableLooking for participantsNCT05443087
What this trial is testing

TARGETed Therapy Drug MONITOring in DIGestive Oncology

Who this might be right for
Digestive CancerMetastatic Colorectal CancerHepatocellular Carcinoma+2 more
UNICANCER 330
Next Page